North America Analysis

Pharma News

cbd oil for pain

CBD oil for pain: What the research shows

Oils by Simpson of 2012 supplies organic full-spectrum CBD cannabis oil products. CBD oil is popular and commonly used for its potent therapeutic benefits, but what about its effect on pain? Here’s what the research shows.
benefits of veterinary medicines

Canvassing public awareness on veterinary medicines

Roxane Feller, Secretary General of AnimalhealthEurope, explains to us canvassing public awareness on the benefits of veterinary medicines.
BioNTech-Pfizer doses

Commission signs third contract for 1.8 billion BioNTech-Pfizer doses

The European Commission has announced that it has signed a third contract to secure an additional 1.8 billion BioNTech-Pfizer vaccine doses.
logistics and supply chain

Logistics & supply chain will win the COVID-19 war

Professor Richard Wilding argues that biochemistry is winning the battle against coronavirus, but logistics and supply chain will win the war.
UK's cannabis industry

Will 2021 see the UK’s cannabis industry bloom?

John Binns & David Hardstaff from BCL Solicitors LLP, reveal if 2021 will be the year that sees the UK’s cannabis industry bloom.
systems governing veterinary medicines

Benchmarking Regulatory systems governing veterinary medicines – part 2

Rick Clayton, Technical Director, AnimalhealthEurope, in the second chapter of this three-part series, continues to examine Benchmarking Regulatory systems governing veterinary medicines.
COVID vaccine development

Why COVID vaccine development was exceptionally speedy

Ram May-Ron, Managing Partner at FreeMind Group, explains why COVID vaccine development was exceptionally speedy.
medicines and vaccines

Countries denied access to vaccines they helped develop

A new study has revealed that new medicines and vaccines approved for use in the United States are often unavailable in countries that helped to develop them.
variant vaccines

COVID-19 variant vaccines will be fast-tracked through cutting-edge testing centre

Health Secretary Matt Hancock has announced that vaccines tailored to tackle COVID-19 variants will be fast-tracked through new state-of-the-art labs.
Remdesivir

Combination of remdesivir and hep C drugs effective against COVID-19

A combination of remdesivir and drugs for hepatitis C virus (HCV) have presented strong effectiveness against COVID-19 in a new study.
cbd oil for adhd

CBD oil for ADHD: What the research shows

CBD oil is popular for its wide-ranging therapeutic benefits, but what about its effects on ADHD? Here’s what the research shows.
treatment for COVID-19

Cannabis as a treatment for COVID-19

Kevin William Simpson, CEO and Founder of OilsBySimpson, tells us about the growing evidence around cannabis as a treatment for COVID-19.
novel foods, CBD novel

CBD Novel Foods in the UK

Lead Scientific Officer at Always Pure Organics Andrew Megahy, explains how the UK is now in a prime position for the future of CBD use, due to the Novel Foods Application.
veterinary medicines

Benchmarking Regulatory systems governing veterinary medicines

Rick Clayton, Technical Director, AnimalhealthEurope, unpacks Benchmarking Regulatory systems governing veterinary medicines in this the first of a series of three articles.
falsified medicines

Pharmaceuticals: Falsified medicines

Dr Ash Ramzan, Founder and Principal Consultant, Woodley BioReg Limited, turns the spotlight on falsified medicines in this pharmaceuticals focus.
pharma markets

Why are illegal pharma markets still prevalent today?

Professor Luis Diestre discusses the research and findings of his European Research Council funded Illegal Pharma Project, focussing on the ever popular market for counterfeit pharmaceuticals.
skin care

Cannabidiol, skin homeostasis and acne

Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains the potential of CBD and cannabinoids for skin care.
medicinal cannabis products

The UK’s legalisation of medicinal cannabis

David Hardstaff of BCL’s Cannabis Law & Regulatory team considers the success of the UK’s legalisation of medicinal cannabis products.
drug markets

COVID-19 and drugs in the European neighbourhood partnership countries

The EU drugs agency explores the impact of COVID-19 on drug markets, use and services in the European neighbourhood partnership countries.
Medical cannabis in the UK

Medical cannabis in the UK and the industry’s future

Rick Brar, CEO & Chairman of Brains Bioceutical Corp. explores the landscape of medical cannabis in the UK and the future direction of the industry.

Follow Open Access Government